Unimed Biotech

Unimeddx operates in the in-vitro diagnostics (IVD) market, specializing in the capture and analysis of circulating tumor cells (CTCs). These are tumor cells that detach from the primary tumor and enter the bloodstream, potentially leading to recurrence and metastasis. The company leverages a suite of innovative technologies to develop high-efficiency, high-throughput, and accurate IVD products. These products are designed for professional clinical testing and scientific research services, including genetic analysis, carrier screening, microbial identification, and cancer companion diagnostics. Unimeddx serves healthcare providers, research institutions, and laboratories, offering them advanced tools to improve diagnostic accuracy and patient outcomes. The business model revolves around the sale of IVD products and related services, generating revenue through product sales and service contracts.

Keywords: circulating tumor cells, IVD products, genetic analysis, carrier screening, microbial identification, cancer diagnostics, high throughput, clinical testing, scientific research, innovative technologies.